Bulletin
Investor Alert

Mylan N.V.

NAS: MYL

GO
/marketstate/country/us

After Hours

MYL
/zigman2/quotes/209413137/lastsale

$

14.48

Change

+0.22 +1.54%

Volume

Volume 69,712

Apr 1, 2020, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209413137/lastsale

Today's close

$ 14.91

$ 14.26

Change

-0.65 -4.36%

Day low

Day high

$14.03

$14.87

Open
Open: 14.59

52 week low

52 week high

$12.75

$28.46

Open

Market cap

$7.70B

Average volume

7.82M

P/E ratio

520.44

Rev. per Employee

$326,506

EPS

0.03

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/myl

MarketWatch News on MYL

  1. Pfizer and Mylan Postpone Upjohn Deal. Analysts Aren’t Worried.

    9:10 a.m. March 27, 2020

    - Josh Nathan-Kazis

  2. Mylan Says India’s Lockdown Won’t Affect Drug Production

    2:24 p.m. March 25, 2020

    - Josh Nathan-Kazis

  3. Demand Spikes for a Drug Studied as Covid-19 Cure

    9:57 a.m. March 24, 2020

    - Josh Nathan-Kazis

  4. Mylan to restart production of hydroxychloroquine

    3:49 p.m. March 19, 2020

    - Jaimy Lee

  5. Indian Authorities Cut Some Drug Exports

    4:43 p.m. March 3, 2020

    - Josh Nathan-Kazis

  6. How the Coronavirus Will Challenge the Health-Care Industry

    6:46 p.m. Feb. 28, 2020

    - Josh Nathan-Kazis

  7. A Cautious Yes on Shopify Shares

    8:00 p.m. Feb. 14, 2020

  8. Biogen's stock jump 19% on Tecfidera patent ruling

    2:59 p.m. Feb. 5, 2020

    - Jaimy Lee

  9. Biogen Stock Skyrockets on Major Patent Win

    2:13 p.m. Feb. 5, 2020

    - Josh Nathan-Kazis

  10. Pfizer Stock Is Dropping Because Its Earnings Missed Expectations

    8:41 a.m. Jan. 28, 2020

    - Josh Nathan-Kazis

  11. Pfizer Reports Earnings Today. Here’s What To Expect.

    7:09 a.m. Jan. 28, 2020

    - Josh Nathan-Kazis

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/myl

Other News on MYL

  1. Ranitidine products to be removed from U.S. market - FDA

    11:52 a.m. Today

    - Seeking Alpha

  2. UBS unconvinced with efficacy of malaria drug for COVID-19

    10:31 a.m. Today

    - Seeking Alpha

  3. RBC Capital Sticks to Its Buy Rating for Mylan (MYL)

    9:08 a.m. March 27, 2020

    - SmarterAnalyst

  4. India clamps down on export of malaria drug for Covid-19

    9:57 a.m. March 26, 2020

    - Seeking Alpha

  5. Close of Mylan/Upjohn tie-up extended to H2

    7:11 a.m. March 26, 2020

    - Seeking Alpha

  6. Selloff in Mylan over India exposure overdone - RBC

    3:13 p.m. March 25, 2020

    - Seeking Alpha

  7. AbbVie: Set To Retrace To Previous Highs

    2:32 p.m. March 25, 2020

    - Seeking Alpha

  8. Mylan down 4% on potential EpiPen safety issue

    1:57 p.m. March 24, 2020

    - Seeking Alpha

  9. How Coronavirus Stocks Are Holding Up

    9:34 a.m. March 24, 2020

    - 247WallSt.com

  10. FDA enacts abbreviated approval pathway for insulin biosimilars

    2:12 p.m. March 23, 2020

    - Seeking Alpha

  11. Trump goes all-in on anti-malarial treatment

    10:33 a.m. March 21, 2020

    - Seeking Alpha

  12. Trump goes all-in on malaria drug for coronavirus infection

    10:33 a.m. March 21, 2020

    - Seeking Alpha

  13. Doctors Turn to Malaria Drugs as Potential Coronavirus Treatment

    7:13 p.m. March 20, 2020

    - Jared S. Hopkins

  14. Will Coronavirus Stocks End the Week With a Bang or a Whimper?

    11:05 a.m. March 20, 2020

    - 247WallSt.com

  15. Loading more headlines...
/news/pressrelease/company/us/myl

Press Releases on MYL

  1. Amlodipine Besylater Market May Set New Growth Story | Pfizer, Mylan, Apotex

    3:01 p.m. March 30, 2020

    - HTF Market Intelligence

  2. Mylan N.v. Ordinary Shares $MYL Trading Report

    2:35 p.m. March 30, 2020

    - Stock Traders Daily

  3. Intrauterine Contraceptive Devices (IUD) demand Predicted to Rising

    12:35 p.m. March 26, 2020

    - Industry News Wire

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.